FELIPE
VILARDELL VILLELLAS
CON
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublications in collaboration with researchers from GlaxoSmithKline (United Kingdom) (1)
2023
-
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells
Science advances, Vol. 9, Núm. 42, pp. eadi0244